NOVARTIS AG (NVSEF)
Clinical trial NCT06430671 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-12-01 → 2025-12-23 3. primary completion date: 2025-12-01 → 2025-12-23
Clinical trial NCT06430671 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-12-01 → 2025-12-23 3. primary completion date: 2025-12-01 → 2025-12-23
📉 **NEGATIVE** • Low confidence analysis (53%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (45%) **Content type:** Clinical